Emanuela Scarpi

Meldola, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 231 publications

Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

Reply to: Time-Varying Effects of Copy Number Alteration Clustering: Methodologic Concerns in Survival Analysis of Relapsed/Refractory Germ Cell Tumors.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 27, 2026

Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer.

Bevacizumab and Platinum Choice in Pembrolizumab-Treated Advanced Cervical Cancer.

Journal: JAMA network open

Published: July 14, 2026

Multiparametric whole-body magnetic resonance imaging in breast cancer management: A prospective study.

Multiparametric whole-body magnetic resonance imaging in breast cancer management: A prospective study.

Journal: Tumori

Published: June 04, 2026

Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients.

Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients.

Journal: Frontiers in oncology

Published: May 08, 2026

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 19, 2026

Primary or specialist care at home: multicenter validation study of the "CP.BA.SPE 2025" questionnaire for the identification of the level of palliative care in advanced cancer patients.

Primary or specialist care at home: multicenter validation study of the "CP.BA.SPE 2025" questionnaire for the identification of the level of palliative care in advanced cancer patients.

Journal: BMC palliative care

Published: January 12, 2026

Survey on cancer patients' attitudes towards AI and data protection: A cross-sectional study from an Italian cancer center.

Survey on cancer patients' attitudes towards AI and data protection: A cross-sectional study from an Italian cancer center.

Journal: International journal of medical informatics

Published: August 11, 2025

Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study.

Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: July 29, 2025

The use of methadone in Italian hospices: an updated survey.

The use of methadone in Italian hospices: an updated survey.

Journal: Annals of palliative medicine

Published: May 22, 2025

CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cancer.

CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cancer.

Journal: BMC cancer

Published: April 11, 2025

Circulating Tumor Cells in Early Breast Cancer: A 10-Year Follow-Up Update.

Circulating Tumor Cells in Early Breast Cancer: A 10-Year Follow-Up Update.

Journal: Biomedicines

Published: April 09, 2025

Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial.

Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial.

Journal: Journal of translational medicine

Published: January 28, 2025

Showing 1-12 of 231

Last Updated: 09/26/2026